Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr.

Literature DB >> 6061376

Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr.

G T Lesser, S Deutsch.

Abstract

Entities: Species

Mesh：

Substances：

Year: 1967 PMID： 6061376 DOI： 10.1152/jappl.1967.23.5.621

Source DB: PubMed Journal: J Appl Physiol ISSN： 0021-8987 Impact factor: 3.531

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

1. Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome.

Authors: Dinesh Pal; Meredith E Walton; William J Lipinski; Lauren G Koch; Ralph Lydic; Steve L Britton; George A Mashour
Journal: Anesth Analg Date: 2011-12-13 Impact factor: 5.108

Review 2. Effects of obesity on pharmacokinetics implications for drug therapy.

Authors: G Cheymol
Journal: Clin Pharmacokinet Date: 2000-09 Impact factor: 6.447

3. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

Authors: Simone van Kralingen; Margot Taks; Jeroen Diepstraten; Ewoudt M van de Garde; Eric P van Dongen; Marinus J Wiezer; Bert van Ramshorst; Bart Vlaminckx; Vera H Deneer; Catherijne A Knibbe
Journal: Eur J Clin Pharmacol Date: 2011-04-16 Impact factor: 2.953

4. Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Authors: Felix Stader; Marco Siccardi; Manuel Battegay; Hannah Kinvig; Melissa A Penny; Catia Marzolini
Journal: Clin Pharmacokinet Date: 2019-04 Impact factor: 6.447

Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr.

1. Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome.

Review 2. Effects of obesity on pharmacokinetics implications for drug therapy.

3. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

4. Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Review 5. Techniques of measurement of body composition. Part II.

6. Healthy lifestyle impact on breast cancer-specific and all-cause mortality.

7. Context-sensitive decrement times for inhaled anesthetics in obese patients explored with Gas Man®.

8. Retrospective review of propofol dosing for procedural sedation in pediatric patients.

Review 9. Clinical pharmacokinetics of drugs in obesity. An update.

Review 10. Body mass index and the efficacy of acid-mediating agents for GERD.